4-((1-(tert-Butoxycarbonyl)azetidin-3-yl)oxy)benzoic acid

Catalog No. :
ACCJOD523
CAS No. :
1259323-78-8
Molecular Formula :
C15H19NO5
Molecular Weight :
293.32

IUPAC Name:4-((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)benzoic acid

4-((1-(tert-Butoxycarbonyl)azetidin-3-yl)oxy)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$167.00Login to see priceIn stockInquiry
5g95%$500.00Login to see priceIn stockInquiry
25g95%$2089.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((1-(tert-Butoxycarbonyl)azetidin-3-yl)oxy)benzoic acid
IUPAC Name4-((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)benzoic acid
MDL No.MFCD18089675
Molecular FormulaC15H19NO5
Molecular Weight293.32
SMILESO=C(O)C1=CC=C(OC2CN(C(OC(C)(C)C)=O)C2)C=C1
InChI KeyBWILLSLXSIKGTH-UHFFFAOYSA-N
Synonym4-([1-(Tert-Butoxycarbonyl)Azetidin-3-Yl]Oxy)Benzoic Acid(WX612175);4-{[1-(tert-Butoxycarbonyl)azetidin-3-yl]-oxy}benzoic acid;4-[1-[(2-Methylpropan-2-yl)oxycarbonyl]azetidin-3-yl]oxybenzoic acid;1-Azetidinecarboxylic acid, 3-(4-carboxyphenoxy)-, 1-(1,1-dimethylethyl) ester;1-(1,1-Dimethylethyl) 3-(4-carboxyphenoxy)-1-azetidinecarboxylate
CAS No.1259323-78-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCJOD523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCJOD523 route product structure diagram
    ACCJOD5231259323-78-8 In Stock
Inquiry

2. ACCJOD523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCJOD523 route product structure diagram
    ACCJOD5231259323-78-8 In Stock
Inquiry

Comments (0)